Page 192 - Read Online
P. 192

Page 10 of 13                                                  Berezin et al. Vessel Plus 2020;4:15  I  http://dx.doi.org/10.20517/2574-1209.2020.03

               Availability of data and materials
               Not applicable.


               Financial support and sponsorship
               None.


               Conflicts of interest
               All authors declared that there are no conflicts of interest.


               Ethical approval and consent to participate
               Not applicable.

               Consent for publication
               Not applicable.


               Copyright
               © The Author(s) 2020.

               REFERENCES
               1.   Herrington W, Lacey B, Sherliker P, Armitage J, Lewington S. Epidemiology of atherosclerosis and the potential to reduce the global
                   burden of atherothrombotic disease. Circ Res 2016;118:535-46.
               2.   Barquera S, Pedroza-Tobías A, Medina C, Hernández-Barrera L, Bibbins-Domingo K, et al. Global overview of the epidemiology of
                   atherosclerotic cardiovascular disease. Arch Med Res 2015;46:328-38.
               3.   Moran AE, Tzong KY, Forouzanfar MH, Rothy GA, Mensah GA, et al. Variations in ischemic heart disease burden by age, country, and
                   income: the Global Burden of Diseases, Injuries, and Risk Factors 2010 study. Glob Heart 2014;9:91-9.
               4.   Cairns BJ, Balkwill A, Canoy D, Green J, Reeves GK, et al.; Million Women Study Collaborators. Variations in vascular mortality trends,
                   2001-2010, among 1.3 million women with different lifestyle risk factors for the disease. Eur J Prev Cardiol 2015;22:1626-34.
               5.   Li K, Hüsing A, Kaaks R. Lifestyle risk factors and residual life expectancy at age 40: a German cohort study. BMC Med 2014;12:59.
               6.   Gimbrone MA Jr, García-Cardeña G. Endothelial cell dysfunction and the pathobiology of atherosclerosis. Circ Res 2016;118:620-36.
               7.   Horio E, Kadomatsu T, Miyata K, Arai Y, Hosokawa K, et al. Role of endothelial cell-derived angptl2 in vascular inflammation leading to
                   endothelial dysfunction and atherosclerosis progression. Arterioscler Thromb Vasc Biol 2014;34:790-800.
               8.   Stoll G, Bendszus M. Inflammation and atherosclerosis: novel insights into plaque formation and destabilization. Stroke 2006;37:1923-32.
               9.   Libby P, Bornfeldt KE, Tall AR. Atherosclerosis: successes, surprises, and future challenges. Circ Res 2016;118:531-4.
               10.  Rader DJ. Human genetics of atherothrombotic disease and its risk factors. Arterioscler Thromb Vasc Biol 2015;35:741-7.
               11.  Dron JS, Ho R, Hegele RA. Recent advances in the genetics of atherothrombotic disease and its determinants. Arterioscler Thromb Vasc
                   Biol 2017;37:e158-66.
               12.  Boulanger CM, Loyer X, Rautou PE, Amabile N. Extracellular vesicles in coronary artery disease. Nat Rev Cardiol 2017;14:259-72.
               13.  Nguyen MA, Karunakaran D, Geoffrion M, Cheng HS, Tandoc K, et al. Extracellular vesicles secreted by atherogenic macrophages
                   transfer microRNA to inhibit cell migration. Arterioscler Thromb Vasc Biol 2018;38:49-63.
               14.  Deng W, Tang T, Hou Y, Zeng Q, Wang Y, et al. Extracellular vesicles in atherosclerosis. Clin Chim Acta 2019;495:109-17.
               15.  Hafiane A, Daskalopoulou SS. Extracellular vesicles characteristics and emerging roles in atherosclerotic cardiovascular disease.
                   Metabolism 2018;85:213-22.
               16.  Boilard E. Extracellular vesicles and their content in bioactive lipid mediators: more than a sack of microRNA. J Lipid Res
                   2018;59:2037-46.
               17.  Théry C, Witwer KW, Aikawa E, Alcaraz MJ, Anderson JD, et al. Minimal information for studies of extracellular vesicles 2018
                   (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines. J
                   Extracell Vesicles 2018;7:1535750.
               18.  Clayton A, Boilard E, Buzas EI, Cheng L, Falcón-Perez JM, et al. Considerations towards a roadmap for collection, handling and storage
                   of blood extracellular vesicles. J Extracell Vesicles 2019;8:1647027.
               19.  Hill AF, Pegtel DM, Lambertz U, Leonardi T, O’Driscoll L, et al. ISEV position paper: extracellular vesicle RNA analysis and
                   bioinformatics. J Extracell Vesicles 2014;2:22859.
               20.  Raimondo F, Morosi L, Chinello C, Magni F, Pitto M. Advances in membranous vesicle and exosome proteomics improving biological
                   understanding and biomarker discovery. Proteomics 2011;11:709-20.
               21.  Corrado C, Raimondo S, Chiesi A, Ciccia F, De Leo G, et al. Exosomes as intercellular signaling organelles involved in health and
                   disease: basic science and clinical applications. Int J Mol Sci 2013;14:5338-66.
               22.  Tual-Chalot S, Leonetti D, Andriantsitohaina R, Martinez MC. Microvesicles: intercellular vectors of biological messages. Mol Interv
   187   188   189   190   191   192   193   194   195   196   197